HRP980317B1 - Pharmaceutical aerosol composition - Google Patents

Pharmaceutical aerosol composition

Info

Publication number
HRP980317B1
HRP980317B1 HR980317A HRP980317A HRP980317B1 HR P980317 B1 HRP980317 B1 HR P980317B1 HR 980317 A HR980317 A HR 980317A HR P980317 A HRP980317 A HR P980317A HR P980317 B1 HRP980317 B1 HR P980317B1
Authority
HR
Croatia
Prior art keywords
aerosol composition
pharmaceutical aerosol
pharmaceutical
composition
aerosol
Prior art date
Application number
HR980317A
Other languages
English (en)
Inventor
David Lewis
Davis Ganderton
Brian Meakin
Paolo Ventura
Gaetano Brambilla
Rafaella Garzia
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10814179&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP980317(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of HRP980317A2 publication Critical patent/HRP980317A2/hr
Publication of HRP980317B1 publication Critical patent/HRP980317B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HR980317A 1997-06-13 1998-06-12 Pharmaceutical aerosol composition HRP980317B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9712434A GB2326334A (en) 1997-06-13 1997-06-13 Pharmaceutical aerosol compositions

Publications (2)

Publication Number Publication Date
HRP980317A2 HRP980317A2 (en) 1999-04-30
HRP980317B1 true HRP980317B1 (en) 2002-06-30

Family

ID=10814179

Family Applications (1)

Application Number Title Priority Date Filing Date
HR980317A HRP980317B1 (en) 1997-06-13 1998-06-12 Pharmaceutical aerosol composition

Country Status (45)

Country Link
EP (2) EP0920302B2 (xx)
JP (1) JP4380802B2 (xx)
KR (1) KR100546239B1 (xx)
CN (1) CN1138532C (xx)
AR (1) AR012977A1 (xx)
AT (1) ATE222751T1 (xx)
AU (1) AU729966B2 (xx)
BG (1) BG63906B1 (xx)
BR (1) BR9805993B1 (xx)
CA (1) CA2263445C (xx)
CO (1) CO4940408A1 (xx)
CZ (1) CZ295521B6 (xx)
DE (1) DE69807420T3 (xx)
DK (1) DK0920302T4 (xx)
DZ (1) DZ2516A1 (xx)
EA (1) EA001259B1 (xx)
EE (1) EE03664B1 (xx)
ES (1) ES2182351T5 (xx)
GB (1) GB2326334A (xx)
GE (1) GEP20012462B (xx)
HK (1) HK1022271A1 (xx)
HR (1) HRP980317B1 (xx)
HU (1) HU228487B1 (xx)
ID (1) ID21491A (xx)
IL (1) IL128484A (xx)
IN (1) IN189317B (xx)
IS (1) IS2435B (xx)
IT (1) IT1293803B1 (xx)
MA (1) MA26507A1 (xx)
ME (2) MEP44008A (xx)
MY (1) MY119074A (xx)
NO (1) NO327775B1 (xx)
NZ (1) NZ334149A (xx)
PL (1) PL193721B1 (xx)
PT (1) PT920302E (xx)
RS (1) RS51274B (xx)
SA (1) SA98190821B1 (xx)
SI (1) SI0920302T2 (xx)
SK (1) SK284430B6 (xx)
TN (1) TNSN98087A1 (xx)
TR (1) TR199900288T1 (xx)
TW (1) TW555570B (xx)
UA (1) UA70289C2 (xx)
WO (1) WO1998056349A1 (xx)
ZA (1) ZA985136B (xx)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1303788B1 (it) 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
CA2317999C (en) 1999-09-11 2004-11-09 Glaxo Group Limited Pharmaceutical formulation of fluticasone propionate
WO2001037805A1 (en) * 1999-11-23 2001-05-31 Glaxo Group Limited Pharmaceutical formulations of salmeterol
ES2238334T3 (es) * 1999-12-24 2005-09-01 Glaxo Group Limited Formulacion farmaceutica en aerosol de salmeterol y propionato de fluticasona.
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
IT1318514B1 (it) * 2000-05-12 2003-08-27 Chiesi Farma Spa Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
ME00220B (me) 2000-05-22 2010-10-10 Chiesi Farm Spa Stabilne farmaceutske formulacije rastvora za inhalatore odmjerene doze pod pritiskom
AU2002238748A1 (en) * 2001-03-12 2002-09-24 Glaxo Group Limited Pharmaceutical aerosol formulation
SI1273292T1 (en) 2001-07-02 2004-12-31 Chiesi Farmaceutici S.P.A. Optimised formulation of tobramycin for aerosolization
EP1340503A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Solution aerosol formulation containing esters of 3, 17-dihydroxy oestratriene derivates for pulmonary delivery
ME00077B (me) 2002-03-01 2010-06-10 Chiesi Farm Spa Formoterol najfiniji preparat
EP1340492A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
DE10214263A1 (de) * 2002-03-28 2003-10-16 Boehringer Ingelheim Pharma HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
EP1369113B1 (en) * 2002-06-06 2006-11-22 CHIESI FARMACEUTICI S.p.A. Solubilisation of drugs in HFA propellant by means of emulsions
AU2003293528A1 (en) * 2003-02-04 2004-09-06 Chrysalis Technologies Incorporated Perfluorocarbon and hydrofluorocarbon formulations and methods of making and using same
EP1915985A1 (en) 2003-03-20 2008-04-30 Boehringer Ingelheim Pharmaceuticals Inc. Formulation for a Metered Dose Inhaler Using Hydro-Fluoro-Alkanes as Propellants
ATE390125T1 (de) * 2003-03-20 2008-04-15 Boehringer Ingelheim Pharma Formulierung für einen dosierinhalator unter verwendung von hydro-fluoro-alkanen als treibstoffe
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
ES2391563T5 (es) 2004-07-02 2022-10-26 Boehringer Ingelheim Int Formulaciones en suspensión de aerosol con TG 227 ea como agente propulsor
DE102006017320A1 (de) 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
GB0621707D0 (en) 2006-10-31 2006-12-13 Univ London Pharmacy Formulations for delivery via pressurised metered dose inhalers
GB0712454D0 (en) 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions
CN101909652A (zh) * 2007-11-07 2010-12-08 阿斯利康(瑞典)有限公司 含有抗坏血酸衍生物的干粉制剂
KR101798691B1 (ko) * 2010-09-06 2017-11-16 키에시 파르마슈티시 엣스. 피. 에이. 계량된-투여량 흡입기 및 계량된-투여량 흡입기의 사용 방법
JP5409594B2 (ja) * 2010-12-22 2014-02-05 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ 加圧式定量吸入器のための安定な製薬学的溶液製剤
WO2013127738A1 (de) 2012-02-28 2013-09-06 Boehringer Ingelheim International Gmbh Neue treibgashaltige tiotropium-formulierung
RU2504402C1 (ru) * 2012-11-20 2014-01-20 Шолекс Девелопмент Гмбх Ингаляционный состав в форме аэрозоля для лечения бронхиальной астмы и хронической обструктивной болезни легких
GB201402513D0 (en) 2014-02-13 2014-04-02 Cardiff Scintigraphics Ltd Pressurised metered dose inhalers and method of manufacture
WO2016018892A1 (en) 2014-07-29 2016-02-04 3M Innovative Properties Company Method of preparing a pharmaceutical composition
WO2017167737A1 (en) 2016-03-31 2017-10-05 Chiesi Farmaceutici S.P.A. Aerosol inhalation device
ES2841649T5 (es) * 2016-09-19 2024-04-24 Mexichem Fluor Sa De Cv Composición farmacéutica

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU601176B2 (en) † 1986-03-10 1990-09-06 Kurt Burghart Benzodiazepine aerosols
ATE71520T1 (de) † 1986-03-10 1992-02-15 Burghart Kurt Pharmazeutische zubereitung sowie verfahren zur herstellung derselben.
US4899874A (en) † 1988-04-26 1990-02-13 Rehrig-Pacific Company, Inc. Stackable low depth bottle case
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
US5225183A (en) † 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
DE3905726A1 (de) * 1989-02-24 1990-08-30 Hoechst Ag Druckgaspackung und treibmittel fuer aerosole
DE69105212T2 (de) † 1990-10-18 1995-03-23 Minnesota Mining & Mfg Aerosolzubereitung, die beclometason 17,21-dipropionat enthält.
GB9024365D0 (en) * 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
DE69231991T2 (de) * 1991-06-10 2002-04-04 Schering Corp Fluorchlorkohlenwasserstofffreie Aerosolformulierungen
PT656207E (pt) † 1991-06-10 2001-11-30 Schering Corp Formulacoes de aerossois sem clorofluorocarbonetos
DE4123663A1 (de) * 1991-07-17 1993-01-21 Schwabe Willmar Gmbh & Co Aerosol-zubereitung und verwendung eines treibmittels dafuer
DE4123668A1 (de) * 1991-07-17 1993-01-21 Rovema Gmbh Verfahren und vorrichtung zur zufuehrung von folienmaterial zu einer intermittierend arbeitenden schlauchbeutelmaschine
ATE128350T1 (de) * 1991-12-12 1995-10-15 Glaxo Group Ltd Pharmazeutische aerosolformulierung.
ATE150296T1 (de) * 1991-12-18 1997-04-15 Minnesota Mining & Mfg Aerosolzusammensetzungen für arzneimittelsuspensionen
KR100312357B1 (ko) * 1992-12-09 2002-04-24 데이비드 이. 프랭크하우저 안정화된약제의에어로졸용액제제
US5502076A (en) * 1994-03-08 1996-03-26 Hoffmann-La Roche Inc. Dispersing agents for use with hydrofluoroalkane propellants
US5508023A (en) * 1994-04-11 1996-04-16 The Center For Innovative Technology Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
US5534242A (en) † 1994-05-02 1996-07-09 Henry; Richard A. Lidocaine-vasoconstrictor aerosol preparation
DE69523301T2 (de) † 1994-05-13 2002-07-04 Aradigm Corp Ein narkotikum enthaltende aerosolformulierung
US5653961A (en) † 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
US5635161A (en) † 1995-06-07 1997-06-03 Abbott Laboratories Aerosol drug formulations containing vegetable oils
GB9517998D0 (en) † 1995-09-04 1995-11-08 Bioglan Lab Ltd Compositions and device for their administration
EP0914143A1 (en) * 1996-07-08 1999-05-12 Rhone-Poulenc Rorer Limited Medicinal cyclosporin-a aerosol solution formulation
NZ336049A (en) † 1996-12-04 2000-09-29 Bioglan Ireland R & D Ltd Aersol device for administering pharmaceutical active agents in a solution of propellant, carrier and valve means for delivering this to the exterior of the container
AU718967B2 (en) † 1997-02-05 2000-05-04 Jagotec Ag Medical aerosol formulations

Also Published As

Publication number Publication date
BG63906B1 (bg) 2003-06-30
ATE222751T1 (de) 2002-09-15
CZ46299A3 (cs) 1999-07-14
ID21491A (id) 1999-06-17
TW555570B (en) 2003-10-01
CN1229355A (zh) 1999-09-22
HRP980317A2 (en) 1999-04-30
EP1219293A3 (en) 2003-05-28
IS2435B (is) 2008-10-15
ITMI971798A1 (it) 1999-01-28
DK0920302T3 (da) 2002-12-23
HK1022271A1 (en) 2000-08-04
TR199900288T1 (xx) 1999-09-21
DK0920302T4 (da) 2006-10-09
SI0920302T1 (en) 2002-12-31
HU228487B1 (en) 2013-03-28
MEP44008A (en) 2011-02-10
NZ334149A (en) 2000-07-28
GB9712434D0 (en) 1997-08-13
ES2182351T5 (es) 2007-03-16
AU8626298A (en) 1998-12-30
DZ2516A1 (fr) 2004-11-08
DE69807420T3 (de) 2006-11-16
EE03664B1 (et) 2002-04-15
EA001259B1 (ru) 2000-12-25
NO327775B1 (no) 2009-09-21
DE69807420D1 (de) 2002-10-02
PT920302E (pt) 2002-11-29
UA70289C2 (uk) 2004-10-15
IN189317B (xx) 2003-02-08
ES2182351T3 (es) 2003-03-01
SI0920302T2 (sl) 2006-10-31
HUP0001339A3 (en) 2000-10-30
EA199900201A1 (ru) 1999-06-24
NO990594D0 (no) 1999-02-09
CA2263445A1 (en) 1998-12-17
PL331531A1 (en) 1999-07-19
JP4380802B2 (ja) 2009-12-09
PL193721B1 (pl) 2007-03-30
YU6999A (sh) 2000-03-21
ME00333B (me) 2011-02-10
EP0920302B1 (en) 2002-08-28
BR9805993A (pt) 1999-08-31
WO1998056349A1 (en) 1998-12-17
SK284430B6 (sk) 2005-04-01
BR9805993B1 (pt) 2009-05-05
EP0920302A1 (en) 1999-06-09
AU729966B2 (en) 2001-02-15
ZA985136B (en) 1999-01-07
NO990594L (no) 1999-04-13
CN1138532C (zh) 2004-02-18
KR100546239B1 (ko) 2006-01-26
BG103221A (en) 1999-09-30
GEP20012462B (en) 2001-06-25
CO4940408A1 (es) 2000-07-24
IL128484A0 (en) 2000-01-31
IS4974A (is) 1999-02-11
EP1219293A2 (en) 2002-07-03
CA2263445C (en) 2008-09-09
CZ295521B6 (cs) 2005-08-17
SA98190821B1 (ar) 2006-11-19
IL128484A (en) 2004-09-27
JP2000516965A (ja) 2000-12-19
EP0920302B2 (en) 2006-06-21
KR20000068171A (ko) 2000-11-25
EE9900055A (et) 1999-08-16
MA26507A1 (fr) 2004-12-20
RS51274B (sr) 2010-12-31
TNSN98087A1 (fr) 2005-03-15
MY119074A (en) 2005-03-31
AR012977A1 (es) 2000-11-22
HUP0001339A2 (hu) 2000-09-28
DE69807420T2 (de) 2003-05-08
GB2326334A (en) 1998-12-23
SK17699A3 (en) 1999-07-12
IT1293803B1 (it) 1999-03-10

Similar Documents

Publication Publication Date Title
HRP980317B1 (en) Pharmaceutical aerosol composition
HUT77377A (hu) Aeroszol készítmények
GB9706089D0 (en) Pharmaceutical composition
GB9727053D0 (en) Pharmaceutical compositions
CY2569B1 (en) Pharmaceutical compositions
IL133928A0 (en) Pharmaceutical composition containing peptichemio
GB9717444D0 (en) Pharmaceutical composition
HUP0002455A3 (en) Gastric-retained pharmaceutical composition
GB9717428D0 (en) Pharmaceutical composition
GB9723985D0 (en) Pharmaceutical compositions
GB9726735D0 (en) Pharmaceutical compositions
HU9700632D0 (en) Pharmaceutical compositions
GB9717770D0 (en) Pharmaceutical composition
GB2321190B (en) Pharmaceutical composition
GB9921495D0 (en) Pharmaceutical compositions
GB9726781D0 (en) Pharmaceutical composition
GB9710525D0 (en) Pharmaceutical composition
GB9702517D0 (en) Pharmaceutical composition
HU9701598D0 (en) Pharmaceutical composition
ZA981391B (en) Pharmaceutical composition
GB9715614D0 (en) Pharmaceutical composition
GB9712097D0 (en) Pharmaceutical composition
GB9710632D0 (en) Pharmaceutical composition
GB9727238D0 (en) Pharmaceutical composition
GB9717575D0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20170523

Year of fee payment: 20

PB20 Patent expired after termination of 20 years

Effective date: 20180612